Zdrowie i gospodarka · 20.05.1994
Food and Drug Administration
The Food and Drug Administration (FDA) is announcing an opportunity for a hearing on a proposal to revoke the establishment and product licenses of Central Georgia Plasma Labs, Inc., due to significant noncompliance with biologics regulations.